Medicover Future Growth
Future criteria checks 4/6
Medicover is forecast to grow earnings and revenue by 38.2% and 14.5% per annum respectively. EPS is expected to grow by 40.2% per annum. Return on equity is forecast to be 18.6% in 3 years.
Key information
38.2%
Earnings growth rate
40.2%
EPS growth rate
| Healthcare earnings growth | 32.0% |
| Revenue growth rate | 14.5% |
| Future return on equity | 18.6% |
| Analyst coverage | Low |
| Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects
Apr 22
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings
Apr 04Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price
Feb 11Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture
Dec 20Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Dec 02Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business
Sep 12Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet
Aug 21Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?
Jun 12Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends
May 27Is Medicover (STO:MCOV B) Using Too Much Debt?
May 12Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes
Feb 16Is Medicover (STO:MCOV B) Using Too Much Debt?
Jan 30Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?
Dec 30Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)
Dec 17Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger
Oct 30Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Oct 16Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?
Sep 09Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)
Jul 25Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Jul 12Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)
Jun 13At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?
May 29With EPS Growth And More, Medicover (STO:MCOV B) Is Interesting
Apr 20Medicover (STO:MCOV B) Could Easily Take On More Debt
Apr 08Medicover (STO:MCOV B) Is Doing The Right Things To Multiply Its Share Price
Mar 15Is Now The Time To Look At Buying Medicover AB (publ) (STO:MCOV B)?
Feb 25Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,725 | 97 | 145 | 309 | 2 |
| 12/31/2025 | 2,353 | 63 | 122 | 260 | 3 |
| 12/31/2024 | 2,031 | 27 | 92 | 216 | 3 |
| 3/31/2024 | 1,826 | 22 | 113 | 222 | N/A |
| 12/31/2023 | 1,746 | 18 | 95 | 205 | N/A |
| 9/30/2023 | 1,682 | 8 | 90 | 205 | N/A |
| 6/30/2023 | 1,610 | 6 | 75 | 202 | N/A |
| 3/31/2023 | 1,548 | 2 | 43 | 186 | N/A |
| 12/31/2022 | 1,510 | 12 | 30 | 170 | N/A |
| 9/30/2022 | 1,489 | 37 | 45 | 182 | N/A |
| 6/30/2022 | 1,455 | 59 | 67 | 195 | N/A |
| 3/31/2022 | 1,442 | 88 | 95 | 205 | N/A |
| 12/31/2021 | 1,377 | 102 | 115 | 217 | N/A |
| 9/30/2021 | 1,299 | 93 | 105 | 202 | N/A |
| 6/30/2021 | 1,226 | 90 | 91 | 176 | N/A |
| 3/31/2021 | 1,076 | 52 | 104 | 176 | N/A |
| 12/31/2020 | 998 | 26 | 83 | 155 | N/A |
| 9/30/2020 | 930 | 14 | 75 | 141 | N/A |
| 6/30/2020 | 879 | 4 | 53 | 122 | N/A |
| 3/31/2020 | 884 | 16 | 31 | 100 | N/A |
| 12/31/2019 | 844 | 23 | 24 | 87 | N/A |
| 9/30/2019 | 796 | 19 | 28 | 79 | N/A |
| 6/30/2019 | 751 | 19 | 39 | 86 | N/A |
| 3/31/2019 | 709 | 20 | 40 | 85 | N/A |
| 12/31/2018 | 672 | 22 | 33 | 74 | N/A |
| 9/30/2018 | 643 | 28 | 34 | 75 | N/A |
| 6/30/2018 | 620 | 26 | 22 | 61 | N/A |
| 3/31/2018 | 600 | 23 | 20 | 55 | N/A |
| 12/31/2017 | 580 | 19 | N/A | 50 | N/A |
| 9/30/2017 | 560 | 10 | N/A | 40 | N/A |
| 6/30/2017 | 540 | 9 | N/A | 36 | N/A |
| 3/31/2017 | 522 | 6 | N/A | 31 | N/A |
| 12/31/2016 | 497 | 4 | N/A | 26 | N/A |
| 12/31/2015 | 416 | 8 | N/A | 29 | N/A |
| 12/31/2014 | 365 | 4 | N/A | 22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MCOV B's forecast earnings growth (38.2% per year) is above the savings rate (1%).
Earnings vs Market: MCOV B's earnings (38.2% per year) are forecast to grow faster than the Swedish market (13.5% per year).
High Growth Earnings: MCOV B's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MCOV B's revenue (14.5% per year) is forecast to grow faster than the Swedish market (1.7% per year).
High Growth Revenue: MCOV B's revenue (14.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MCOV B's Return on Equity is forecast to be low in 3 years time (18.6%).